RMD.AX
RMD.AX
AU000000RMD6
RESMED CDI 10:1 [RMD]
Loading chart...
Pure Price Volatility Risk (Market Swings)

The business itself is financially solid (Financial Health 100/100, minimal insolvency risk). The high overall score (7/7) is driven primarily by extreme stock price swings (±28.0% p.a.) and steep historical drawdowns.

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves noticeably less than the broader market (0.8x).

Beta (Market Relation)
0.75x
Defensive
Volatility (5Y p.a.)
28.0% p.a.
5-Year Horizon
Max Drawdown (5Y)
-43.0%
5-Year Horizon
Sharpe Ratio
-0.14
Return / Risk
Speculative / High Risk: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

Timeframe
Volatility (p.a.)
Max Drawdown
Sharpe Ratio
Return (p.a.)
1 Year — — — -23.3%
3 Years 28.4% -42.8% 0.32 +11.9%
5 Years 28.0% -43.0% -0.14 -1.5%
10 Years 27.9% -47.0% 0.43 +14.4%

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
Historical Stress Test: Maximum peak-to-trough drawdown of -47.0% in the extended horizon.
ende